When Inhibitor MET Biomarker: Postmortem or Initium Novum?
JCO Precis Oncol
.
2019:3:PO.18.00359.
doi: 10.1200/PO.18.00359.
Epub 2019 Mar 8.
Author
Daniel V T Catenacci
1
Affiliation
1
The University of Chicago, Chicago, IL.
PMID:
30997444
PMCID:
PMC6463300
DOI:
10.1200/PO.18.00359
No abstract available
Grants and funding
K23 CA178203/CA/NCI NIH HHS/United States